Cited by 357Advanced Drug Delivery SystemsBarrier Structure and Function StudiesNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 217 of the 219 references it cites were found in a registry or an index.

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Open access

Bourganis, Vassilis, Kammona, Olga, Alexopoulos, Aleck, Kiparissides, Costas·2018·European Journal of Pharmaceutics and Biopharmaceutics

DOI 10.1016/j.ejpb.2018.05.009

Open this paper in CoChat — free account Open PDF

Abstract

Central nervous system (CNS) disorders (e.g., multiple sclerosis, Alzheimer's disease, etc.) represent a growing public health issue, primarily due to the increased life expectancy and the aging population. The treatment of such disorders is notably elaborate and requires the delivery of therapeutics to the brain in appropriate amounts to elicit a pharmacological response. However, despite the major advances both in neuroscience and drug delivery research, the administration of drugs to the CNS still remains elusive. It is commonly accepted that effectiveness-related issues arise due to the inability of parenterally administered macromolecules to cross the Blood-Brain Barrier (BBB) in order to access the CNS, thus impeding their successful delivery to brain tissues. As a result, the direct Nose-to-Brain delivery has emerged as a powerful strategy to circumvent the BBB and deliver drugs to the brain. The present review article attempts to highlight the different experimental and computational approaches pursued so far to attain and enhance the direct delivery of therapeutic agents to the brain and shed some light on the underlying mechanisms involved in the pathogenesis and treatment of neurological disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ejpb.2018.05.009

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 3,037
Macromolecular Crowding and Confinement: Biochemical, Biophysical, and Potential Physiological Consequences
Zhou, H., Rivas, G., & Minton, A. P. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125817 · Cited by 2,160
Nanoemulsions versus microemulsions: terminology, differences, and similarities
McClements, D. J. (2011) · Soft Matter · doi:10.1039/c2sm06903b · Cited by 1,786
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,494
Barrier properties of mucus
Cone, R. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.
Abuchowski, A., Es, T. V., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,293
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
Abuchowski, A., McCoy, J. R., Palczuk, N. C., Es, T. V., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,276
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,256

Show all 219 references

Research works printed but not linked: 5

M. Dahlin, Nasal administration of compounds active in the Central Nervous System - Exploring the olfactory pathway, Uppsala University, Ph.D Dissertation, (2000).
V. Dhamankar, Cytochrome P450-mediated drug metabolizing activity in the nasal mucosa, The University of Iowa, Ph.D Dissertation, 2013.
Pardeshi, 2015, Novel nasal devices for the efficient drug delivery: A systemic review, Indian J. Nov. Drug Deliv., 7, 1
A. Mistry, The development and application of biological models for evaluation of direct nose-to-brain drug delivery systems. Ph.D Dissertation, University of Nottingham, (2009).
K. Inthavong, K. Zhang, J. Tu, Modelling submicron and micron particle deposition in a human nasal cavity, Seventh International Conference on CFD in the Minerals and Process Industries, CSIRO, Melbourne, Australia, 2009.

Sorted by citations

Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
Gänger, S., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030116 · Cited by 447
Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomes
Wu, I. Y., Bala, S., Škalko-Basnet, N., & di Cagno, M. P. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105026 · Cited by 439
Drug delivery to the central nervous system
Nance, E. A., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 442
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
Costa, C. P., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 317
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
Formica, M. L., Real, D. A., Picchio, M. L., Catlin, E. J., Donnelly, R. F., & Paredes, A. J. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101631 · Cited by 282
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269
Key for crossing the BBB with nanoparticles: the rational design
Lombardo, S. M., Schneider, M., Türeli, A. E., & Günday-Türeli, N. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.72 · Cited by 255
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
Lee, D., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122049 · Cited by 227
Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis
Costa, C. P., Moreira, J. N., Amaral, M. H., Lobo, J. M. S., & Silva, A. C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.049 · Cited by 216
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders
Correia, A. D. A., Monteiro, A. R., Silva, R., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114485 · Cited by 219
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 178
Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
Hong, S.-S., Oh, K. T., Choi, H., & Lim, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11100540 · Cited by 167
Advanced drug delivery 2020 and beyond: Perspectives on the future
Bae, Y. H., & Park, K. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.018 · Cited by 160
Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion
Long, Y., Yang, Q., Xiang, Y., Zhang, Y., Wan, J., Liu, S., Li, N., & Peng, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104795 · Cited by 151
Air-liquid interface (ALI) impact on different respiratory cell cultures
Silva, S., Bicker, J., Falcão, A. C., & Fortuna, A. C. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.01.013 · Cited by 147
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Gandhi, S. J., Shastri, D. H., Shah, J., Nair, A. B., & Jacob, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040481 · Cited by 162
Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges
Kashyap, K., & Shukla, R. (2019) · Current Drug Delivery · doi:10.2174/1567201816666191029122740 · Cited by 147
Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders
Awad, R., Avital, A., & Sosnik, A. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.003 · Cited by 150
Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
Rabiee, N., Ahmadi, S., Afshari, R., Khalaji, S., Rabiee, M., Bagherzadeh, M., Fatahi, Y., Dinarvand, R., Tahriri, M., Tayebi, L., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000076 · Cited by 144
Tight junction modulation at the blood-brain barrier: Current and future perspectives
Hashimoto, Y., & Campbell, M. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183298 · Cited by 138
Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety
Chatzitaki, A., Jesus, S., Karavasili, C., Andreadis, D., Fatouros, D. G., & Borges, O. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119776 · Cited by 143
Neurotoxicology of Nanomaterials
Boyes, W. K., & van Thriel, C. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00050 · Cited by 132
Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs
Clementino, A., Pellegrini, G., Banella, S., Colombo, G., Cantú, L., Sonvico, F., & Favero, E. D. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00366 · Cited by 124
Recent progress in nanocarriers for direct nose to brain drug delivery
Emad, N. A., Ahmed, B., Alhalmi, A., Alzobaidi, N., & Al-Kubati, S. S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102642 · Cited by 114
Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease
Akel, H., Ismail, R., & Csóka, I. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.12.014 · Cited by 113
A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
Cortés, H., Alcalá-Alcalá, S., Caballero-Florán, I. H., Bernal-Chávez, S. A., Ávalos‐Fuentes, A., González‐Torres, M., Carmen, M. G., Figueroa‐González, G., Reyes‐Hernández, O. D., Florán, B., et al. (2020) · Membranes · doi:10.3390/membranes10090212 · Cited by 108
Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders
Rassu, G., Porcu, E. P., Fancello, S., Obinu, A., Senes, N., Galleri, G., Migheli, R., Gavini, E., & Giunchedi, P. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics11010008 · Cited by 107
Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs
Lofts, A., Abu-Hijleh, F. A., Rigg, N., Mishra, R. K., & Hoare, T. R. (2022) · CNS Drugs · doi:10.1007/s40263-022-00930-4 · Cited by 118
Microemulsion-Based Media in Nose-to-Brain Drug Delivery
Froelich, A., Osmałek, T. Z., Jadach, B., Puri, V., & Michniak‐Kohn, B. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020201 · Cited by 110
The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters
Chung, S. S., Peters, J. M., Detyniecki, K., Tatum, W. O., Rabinowicz, A. L., & Carrazana, E. J. (2022) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2022.100581 · Cited by 117
Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma
de Oliveira, E. R., Nascimento, T. L., Salomão, M. A., da Silva, A. C. G., Valadares, M. C., & Lima, E. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2662-z · Cited by 103
Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access
Giovannelli, L., Bari, E., Jommi, C., Tartara, F., Armocida, D., Garbossa, D., Cofano, F., Torre, M. L., & Segale, L. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.013 · Cited by 102
The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
Anderluzzi, G., Lou, G., Woods, S., Schmidt, S., Gallorini, S., Brazzoli, M., Johnson, R., Roberts, C. W., O’Hagan, D. T., Baudner, B. C., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.008 · Cited by 100
Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil
Espinoza, L. C., Silva-Abreu, M., Clares, B., Rodríguez-Lagunas, M. J., Halbaut, L., Cañas, M.-A., & Calpena, A. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020064 · Cited by 99
Curcumin-Loaded Mesoporous Silica Nanoparticles Dispersed in Thermo-Responsive Hydrogel as Potential Alzheimer Disease Therapy
Ribeiro, T. D. C., Sábio, R. M., Luiz, M. T., Canto‐de‐Souza, L., Fonseca‐Santos, B., da Silva, L. C. C., Fantini, M. C. D. A., Planeta, C. S., & Chorilli, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091976 · Cited by 106
Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach
Azambuja, J. H., Schuh, R. S., Michels, L. R., Gelsleichter, N. E., Beckenkamp, L. R., Iser, I. C., Lenz, G. S., de Oliveira, F. H., Venturin, G. T., Greggio, S., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01730-6 · Cited by 96
Different Methods and Formulations of Drugs and Vaccines for Nasal Administration
Tai, J., Han, M. S., Lee, D., Park, I., Lee, S. H., & Kim, T. H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051073 · Cited by 104
Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins
Gabold, B., Adams, F., Brameyer, S., Jung, K., Ried, C. L., Merdan, T., & Merkel, O. M. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01245-z · Cited by 93
Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting
Wang, L., Tang, S., Yu, Y., Lv, Y., Wang, A., Yan, X., Li, N., Sha, C., Sun, K., & Li, Y. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00911 · Cited by 89
Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
Chen, T. C., da Fonseca, C. O., & Schönthal, A. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123905 · Cited by 90
Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review
Zhang, Y., Guo, P., Ma, Z., Lü, P., Kebebe, D., & Liu, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01002-3 · Cited by 92
Insights into nanoparticles-induced neurotoxicity and cope up strategies
Zia, S. K., Aqib, A. I., Muneer, A., Fatima, M., Atta, K., Kausar, T., Zaheer, C.-N. F., Ahmad, I. S., Saeed, M., & Shafique, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1127460 · Cited by 93
Wnt-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes
Zhang, D., Lu, Z., Man, J., Cui, K., Fu, X., Yu, L., Gao, Y., Liao, L., Xiao, Q., Guo, R., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105760 · Cited by 84
Critical Review of Lipid-Based Nanoparticles as Carriers of Neuroprotective Drugs and Extracts
Fernandes, F., Dias-Teixeira, M., Delerue-Matos, C. M., & Grosso, C. (2021) · Nanomaterials · doi:10.3390/nano11030563 · Cited by 81
Nanomodulation of Macrophages in Multiple Sclerosis
Nally, F. K., Santi, C. D., & McCoy, C. E. (2019) · Cells · doi:10.3390/cells8060543 · Cited by 80
Optimization of Curcumin Nanocrystals as Promising Strategy for Nose-to-Brain Delivery Application
Bonaccorso, A., Gigliobianco, M. R., Pellitteri, R., Santonocito, D., Carbone, C., Martino, P. D., Puglisi, G., & Musumeci, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050476 · Cited by 79
Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies
Elsenosy, F. M., Abdelbary, G. A., Elshafeey, A. H., Elsayed, I., & Fares, A. R. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s277352 · Cited by 80
Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma
Ullah, I., Chung, K., Bae, S., Li, Y., Kim, C., Choi, B., Nam, H. Y., Kim, S. H., Yun, C., Lee, K. Y., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01215 · Cited by 76
Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy
Khatri, D. K., Preeti, K., Tonape, S., Bhattacharjee, S., Patel, M., Shah, S., Singh, P. K., Srivastava, S., Gugulothu, D., Vora, L., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x20666220507022701 · Cited by 75
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 79
Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex †
Venuti, V., Crupi, V., Fazio, B., Majolino, D., Acri, G., Testagrossa, B., Stancanelli, R., Gaetano, F. D., Gagliardi, A., Paolino, D., et al. (2019) · Biomolecules · doi:10.3390/biom9100531 · Cited by 74
Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: Insights and challenges
Wu, H., Zhang, T., Li, N., & Gao, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.023 · Cited by 73
Nose-to-brain delivery of levetiracetam after intranasal administration to mice
Gonçalves, J., Bicker, J., Gouveia, F., Liberal, J. M. T., Oliveira, R. C., Alves, G., Falcão, A. C., & Fortuna, A. C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.047 · Cited by 72
Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview
Song, Y. H., De, R., & Lee, K. T. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.103008 · Cited by 78
Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery
Shringarpure, M., Gharat, S., Momin, M. M., & Omri, A. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1823965 · Cited by 70
Using nanotechnology to deliver biomolecules from nose to brain — peptides, proteins, monoclonal antibodies and RNA
Borrajo, M. L., & Alonso, M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01086-2 · Cited by 76
Raman Imaging of Nanocarriers for Drug Delivery
Vanden-Hehir, S., Tipping, W. J., Lee, M. W., Brunton, V. G., Williams, A., & Hulme, A. N. (2019) · Nanomaterials · doi:10.3390/nano9030341 · Cited by 74
Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating
de Oliveira, E. R., dos Santos, L. C. R., Salomão, M. A., Nascimento, T. L., Oliveira, G. D. A. R., Lião, L. M., & Lima, E. M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00816-2 · Cited by 69
Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders
Patharapankal, E. J., Ajiboye, A. L., Mattern, C., & Trivedi, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010066 · Cited by 75
Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia
Li, X., Li, S., Ma, C., Li, T., & Yang, L. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2064564 · Cited by 68
Thermosensitive mucoadhesive in situ gel for intranasal delivery of Almotriptan malate: Formulation, characterization, and evaluation
Verekar, R. R., Gurav, S. S., & Bolmal, U. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101778 · Cited by 67
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 70
Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation
Mohanty, D., Alsaidan, O. A., Zafar, A., Dodle, T., Gupta, J. K., Yasir, M., Mohanty, A., & Khalid, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071985 · Cited by 66
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Tan, M. S. A., Parekh, H. S., Pandey, P. M., Siskind, D. J., & Falconer, J. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1762563 · Cited by 68
Spray dried powders for nasal delivery: Process and formulation considerations
Henriques, P., Fortuna, A. C., & Doktorovová, S. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.05.002 · Cited by 66
Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology
Kumar, R., Aadil, K. R., Mondal, K., Mishra, Y. K., Oupický, D., Ramakrishna, S., & Kaushik, A. K. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.1993126 · Cited by 64
Lipid-based nanoparticles via nose-to-brain delivery: a mini review
Xinchen, Y., Jing, T., & Jiaoqiong, G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1214450 · Cited by 67
Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management
Upadhaya, P. G., Pulakkat, S., & Patravale, V. B. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00747-y · Cited by 62
Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications
Taléns-Visconti, R., de Julián-Ortiz, J. V., Vila-Busó, O., Diez-Sales, O., & Nácher, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051399 · Cited by 59
Nose to Brain Delivery of Phenytoin Sodium Loaded Nano Lipid Carriers: Formulation, Drug Release, Permeation and In Vivo Pharmacokinetic Studies
Nair, S. C., Vinayan, K. P., & Mangalathillam, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101640 · Cited by 59
New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan
Popescu, R., Ghica, M. V., Dinu‐Pîrvu, C., Anuța, V., Lupuliasa, D., & Popa, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145016 · Cited by 57
Fabrication of a Thermosensitive In Situ Gel Nanoemulsion for Nose to Brain Delivery of Temozolomide
Bayanati, M., Khosroshahi, A. G., Alvandi, M., & Mahboobian, M. M. (2021) · Journal of Nanomaterials · doi:10.1155/2021/1546798 · Cited by 57
Sesame Oil-Based Nanostructured Lipid Carriers of Nicergoline, Intranasal Delivery System for Brain Targeting of Synergistic Cerebrovascular Protection
Abourehab, M. A. S., Khames, A., Genedy, S., Mostafa, S., Khaleel, M. A., Omar, M. M., & Sisi, A. M. E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040581 · Cited by 56
Nano-in-Micro-Particles Consisting of PLGA Nanoparticles Embedded in Chitosan Microparticles via Spray-Drying Enhances Their Uptake in the Olfactory Mucosa
Spindler, L. M., Feuerhake, A., Ladel, S., Günday, C., Flamm, J., Günday-Türeli, N., Türeli, A. E., Tovar, G. E. M., Schindowski, K., & Gruber‐Traub, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.732954 · Cited by 54
Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies
Bhanderi, M., Shah, J., Gorain, B., Nair, A. B., Jacob, S., Asdaq, S. M. B., Fattepur, S., Alamri, A. S., Alsanie, W. F., Alhomrani, M., et al. (2021) · Materials · doi:10.3390/ma14216291 · Cited by 53
Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies
Goel, H., Kalra, V., Verma, S. K., Dubey, S. K., & Tiwary, A. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.009 · Cited by 56
Current Nanoparticle Approaches in Nose to Brain Drug Delivery and Anticancer Therapy - A Review
Ansari, M. A., Chung, I., Rajakumar, G., Alzohairy, M. A., Alomary, M. N., Thiruvengadam, M., Pottoo, F. H., & Ahmad, N. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200116153912 · Cited by 54
In vitro investigations on dopamine loaded Solid Lipid Nanoparticles
Cometa, S., Bonifacio, M. A., Trapani, G., Gioia, S. D., Dazzi, L., Giglio, E. D., & Trapani, A. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113257 · Cited by 54
Direct nose to the brain nanomedicine delivery presents a formidable challenge
Yokel, R. A. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1767 · Cited by 53
Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications
Zingale, E., Bonaccorso, A., Carbone, C., Musumeci, T., & Pignatello, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040691 · Cited by 53
In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery
Haasbroek‐Pheiffer, A., Niekerk, S. E. V., van der Kooy, F., Cloete, T. T., Steenekamp, J. H., & Hamman, J. H. (2023) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2348 · Cited by 51
Countermeasures in organophosphorus intoxication: pitfalls and prospects
Górecki, L., Soukup, O., & Korábečný, J. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.04.008 · Cited by 48
Development, characterisation and nasal deposition of melatonin-loaded pectin/hypromellose microspheres
Nižić, L., Potaś, J., Winnicka, K., Szekalska, M., Erak, I., Gretić, M., Jug, M., & Hafner, A. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105115 · Cited by 48
Cyto/Biocompatibility of Dopamine Combined with the Antioxidant Grape Seed-Derived Polyphenol Compounds in Solid Lipid Nanoparticles
Trapani, A., Guerra, L., Corbo, F., Castellani, S., Sanna, E., Capobianco, L., Monteduro, A. G., Manno, D. E., Mandracchia, D., Gioia, S. D., et al. (2021) · Molecules · doi:10.3390/molecules26040916 · Cited by 50
Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges
Prabakaran, A., Agrawal, M., Dethe, M. R., Ahmed, H., Yadav, A. K., Gupta, U. D., & Alexander, A. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2029845 · Cited by 47
Role of Particle Size in Translational Research of Nanomedicines for Successful Drug Delivery: Discrepancies and Inadequacies
Chan, H. W., Chow, S., Zhang, X., Kwok, P. C. L., & Chow, S. F. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.07.002 · Cited by 45
Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases
Jayoush, A. R. A., Hassan, H. A. F. M., Asiri, H., Jafar, M., Saeed, R., Harati, R., & Haider, M. A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105007 · Cited by 50
Synthesis and characterization of novel chitosan-dopamine or chitosan-tyrosine conjugates for potential nose-to-brain delivery
Cassano, R., Trapani, A., Gioia, M. L. D., Mandracchia, D., Pellitteri, R., Tripodo, G., Trombino, S., Gioia, S. D., & Conese, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119829 · Cited by 44
Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
Jin, Z., Han, Y., Zhang, D., Li, Z., Jing, Y., Hu, B., & Sun, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102070 · Cited by 45
Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies
Du, L., Chen, L., Liu, F., Wang, W., & Huang, H. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.05.014 · Cited by 43
A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises
Khodaverdi, K., Bakhshi, A., Mozafari, M. R., & Naghib, S. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134962 · Cited by 45
Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model
Sandbhor, P., Goda, J. S., Mohanty, B. S., Gera, P. B., Yadav, S., Chekuri, G., Chaudhari, P. R., Dutt, S., & Banerjee, R. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01220-8 · Cited by 41
Nose‐to‐brain delivery of nanotherapeutics: Transport mechanisms and applications
Xu, K., Duan, S., Wang, W., Ouyang, Q., Qin, F., Guo, P., Hou, J., He, Z., Wei, W., & Qin, M. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1956 · Cited by 46
Trimethyl Chitosan Hydrogel Nanoparticles for Progesterone Delivery in Neurodegenerative Disorders
Cardia, M. C., Carta, A. R., Caboni, P., Maccioni, A. M., Erbì, S., Boi, L., Meloni, M. C., Lai, F., & Sinico, C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120657 · Cited by 41
The review of nasal drug delivery system: The strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption
Wei, S., Zhai, Z., Kong, X., Wu, C., Zhu, B., Zhao, Z., & Zhang, X. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125584 · Cited by 43
Olfactory Targeting of Microparticles Through Inhalation and Bi-directional Airflow: Effect of Particle Size and Nasal Anatomy
Yarragudi, S. B., Kumar, H., Jain, R., Tawhai, M. H., & Rizwan, S. B. (2020) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2019.1549 · Cited by 40
Intranasal Administration for Pain: Oxytocin and Other Polypeptides
Bharadwaj, V. N., Tzabazis, A., Klukinov, M., Manering, N. A., & Yeomans, D. C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071088 · Cited by 43
Lipid-based nanoparticles and RNA as innovative neuro-therapeutics
Tsakiri, M., Zivko, C., Demetzos, C., & Mahairaki, V. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.900610 · Cited by 39
Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes
Padilla-Godínez, F. J., Ruiz-Ortega, L. I., & Guerra‐Crespo, M. (2022) · Cells · doi:10.3390/cells11213445 · Cited by 40

Authors: Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C.
Affiliations: Aristotle University of Thessaloniki (GR)
Centre for Research and Technology Hellas (GR)
Corresponding author: Kiparissides, Costas
ORCID: Bourganis, Vassilis
Kammona, Olga
Alexopoulos, Aleck
Kiparissides, Costas
Venue: European Journal of Pharmaceutics and Biopharmaceutics
Publisher: Elsevier BV
Published: 2018-07
Volume: 128
Pages: 337-362
ISSN: 0939-6411 (ISSN-L)
DOI: 10.1016/j.ejpb.2018.05.009
OpenAlex: W2801808920
Cited by: 357
References: 219
Citations by year: 2026: 31 · 2025: 39 · 2024: 52 · 2023: 61 · 2022: 53 · 2021: 54 · 2020: 38 · 2019: 23 · 2018: 6
FWCI: 2.63
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: European Journal of Pharmaceutics and Biopharmaceutics (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: European Framework Programme for Research and Innovation Horizon 2020 (721098)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: nose-to-brain delivery, blood-brain barrier, brain drug delivery, central nervous system disorders, multiple sclerosis, Alzheimer's disease, intranasal drug delivery
MeSH terms: Administration, Intranasal, Animals, Biological Transport, Blood-Brain Barrier, Brain, Central Nervous System Agents, Central Nervous System Diseases, Drug Carriers, Epithelium, Humans, Nasal Mucosa, Permeability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks